U.S., March 26 -- ClinicalTrials.gov registry received information related to the study (NCT06894329) titled 'A Study for the PanCystPro Assay in the Management of Pancreatic Cystic Lesions' on March 19.
Brief Summary: The purpose of this research is to learn if the PanCystPro assay can help doctors in making decisions about treatment and monitoring of pancreatic cysts. The PanCystPro test measures glucose, carcinoembryonic antigen (CEA), and gastricsin biomarkers on fluid obtained from a pancreatic cyst. The test reports if the cyst fluid should be considered "Non-mucinous" or "Mucinous". Mucinous pancreatic cysts are more likely to progress to cancer while non-mucinous cysts seldom progress to cancer.
Study Start Date: April 15
Study T...